Wockhardt Limited (WOCKPHARMA) Share Price
NSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE049B01025
Key metrics
- Market Cap
- ₹32,677 Cr
- P/E Ratio
- 78.1
- EPS
- 25.14
- Book Value
- 325
- P/B Ratio
- 6.19
- ROE
- 4.03%
- ROCE
- 5.36%
- Debt / Equity
- 0.42
- Net Margin
- 6.42%
- Revenue Growth
- 13.79%
- Profit Growth
- 553.19%
- Dividend Yield
- —
- 52W High
- ₹2,422.30
- 52W Low
- ₹1,086.70
- Market Cap Band
- large cap
- Face Value
- 5
Ratios computed from the annual results period ending 2026-03-31.
About Wockhardt Limited
Wockhardt Limited, together with its subsidiaries, operates as a pharmaceutical and biotech company, in India, the United States, Europe, and internationally. It manufactures and trades pharmaceuticals, medicinal chemical, and botanical products, as well as chemicals and chemical products. The company also develops its flagship antibiotic, ZAYNICH zidebactam/cefepime, a novel beta lactam enhancer mechanism for the treatment of sepsis and hospital/ventilator associated pneumonia; FOVISCU, an antibiotic for gram-negative infections; MIQNAF nafithromycin, which targets azithromycin-resistant community respiratory pathogens; and ODRATE, a once-daily combination of ertapenem and zidebactam for resistant gram-negative infections through outpatient parenteral antimicrobial therapy. In addition, it develops and commercializes insulin analogs, glucagon-like peptide-1 agonists, and novel combination drug products; Biovac-B, a recombinant hepatitis-B vaccine; Wepox, a recombinant human erythropoietin; Wosulin, a recombinant human insulin; and Glaritus, a recombinant insulin glargine, as well as offers insulin aspart regular and biphasic drug products. Further, the company offers delivery devices for insulin, including DispoPen disposable pen and Mypen reusable pen. Wockhardt Limited was founded in 1967 and is headquartered in Mumbai, India.
- Headquarters
- Mumbai, India
- Employees
- 2,564
- Promoter Holding
- 51.02%
The full Wockhardt Limited analysis
Create a free account to open the complete WOCKPHARMA deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.